15
Participants
Start Date
October 31, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
ADALIMUMAB
Adalimumab at 160/80 mg and maintained on 40 mg eow until next colonoscopy performed at week 48. If before week 48, an increase of more than 50% is observed in calprotectin and/or hsCRP from baseline, over two consecutive follow up visits 2 weeks apart, the colonoscopy will be performed earlier. If patients have still significant endoscopic lesions, adalimumab or adalimumab placebo will be intensified to 40 mg weekly.
Placebo
PLACEBO at 160/80 mg and maintained on 40 mg eow until next colonoscopy performed at week 48. If before week 48, an increase of more than 50% is observed in calprotectin and/or hsCRP from baseline, over two consecutive follow up visits 2 weeks apart, the colonoscopy will be performed earlier. If patients have still significant endoscopic lesions, adalimumab or adalimumab placebo will be intensified to 40 mg weekly
Hospital Erasme Bruxelles, Brussels
Hospital Saint Luc Bruxelles, Brussels
Imeldaziekenhuis Bonheiden, Bonheiden
Centre Hospitalier Universitaire de Liege, Liège
Heiling Hartzieknhuis Roeselare, Roeselare
Hospital University Gent, Ghent
Hospital Universitario Reina Sofia, Córdoba
Hospital Universitario La Princesa, Madrid
Hospital Gregorio Marañón, Madrid
Hospital Ramón y Cajal, Madrid
CHU Bordeaux - Hospital Haut-Leveque, Pessac
Hospital Doctor Negrin, Las Palmas de Gran Canarias
Hospital Virgen del Rocío, Seville
CH Saint Etienne - Hospital Nord, Saint-Etienne
CHU Nantes, Nantes
Hospital Clínico de Valencia, Valencia
Hospital de Manises, Manises
CHRU Reims - Hospital Robert Debre, Reims
CHU Nancy - Hospital de Brabois Adultes, Vandœuvre-lès-Nancy
CHRU Lille - Hospital Claude Huriez, Lille
CHU Lyon Sud, Lyon
Hospital Saint Louis, Paris
CHU Rouen - Hospital Charles Nicolle, Rouen
CHU Tours - Hospital Trousseau, Chambray
CHU Amiens - Hospital Nord, Amiens
Hospital Beaujon, Clichy
Complejo Hospitalario Santiago de Compostela, Santiago de Compostela
Hospital Germans Trias i Pujol, Badalona
Hospital Lozano Blesa, Zaragoza
Hospital Santa Creu i Sant Pau, Barcelona
Collaborators (1)
Abbott
INDUSTRY
TFS Trial Form Support
INDUSTRY
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
OTHER